Geode Capital Management, LLC Ocular Therapeutix, Inc Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,452,087 shares of OCUL stock, worth $30 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,452,087
Previous 2,486,043 38.86%
Holding current value
$30 Million
Previous $22.6 Million 4.38%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$4.2 - $8.69 $4.06 Million - $8.39 Million
966,044 Added 38.86%
3,452,087 $23.6 Million
Q1 2024

May 13, 2024
BUY
$3.85 - $10.93 $2.88 Million - $8.19 Million
749,229 Added 43.14%
2,486,043 $22.6 Million
Q4 2023

Feb 13, 2024
BUY
$2.08 - $4.52 $223,154 - $484,932
107,286 Added 6.58%
1,736,814 $7.75 Million
Q3 2023

Nov 13, 2023
BUY
$3.14 - $5.04 $187,219 - $300,504
59,624 Added 3.8%
1,629,528 $5.12 Million
Q2 2023

Aug 11, 2023
BUY
$4.6 - $7.64 $515,954 - $856,932
112,164 Added 7.69%
1,569,904 $8.1 Million
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $131,372 - $295,235
47,087 Added 3.34%
1,457,740 $7.68 Million
Q4 2022

Feb 13, 2023
BUY
$2.61 - $4.41 $104,139 - $175,959
39,900 Added 2.91%
1,410,653 $3.96 Million
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $79,051 - $125,632
19,328 Added 1.43%
1,370,753 $5.69 Million
Q2 2022

Aug 12, 2022
SELL
$3.01 - $5.22 $37,760 - $65,484
-12,545 Reduced 0.92%
1,351,425 $5.43 Million
Q1 2022

May 13, 2022
BUY
$4.83 - $7.35 $225,227 - $342,737
46,631 Added 3.54%
1,363,970 $6.75 Million
Q4 2021

Feb 11, 2022
BUY
$6.16 - $12.07 $31,440 - $61,605
5,104 Added 0.39%
1,317,339 $9.18 Million
Q3 2021

Nov 12, 2021
BUY
$9.7 - $14.34 $72,129 - $106,632
7,436 Added 0.57%
1,312,235 $13.1 Million
Q2 2021

Aug 13, 2021
BUY
$13.43 - $19.16 $1.01 Million - $1.44 Million
75,191 Added 6.12%
1,304,799 $18.5 Million
Q1 2021

May 12, 2021
BUY
$15.82 - $22.11 $2.2 Million - $3.08 Million
139,257 Added 12.77%
1,229,608 $20.2 Million
Q4 2020

Feb 12, 2021
BUY
$7.91 - $22.95 $1.62 Million - $4.69 Million
204,445 Added 23.08%
1,090,351 $22.6 Million
Q3 2020

Nov 13, 2020
BUY
$7.36 - $9.87 $534,689 - $717,035
72,648 Added 8.93%
885,906 $6.74 Million
Q2 2020

Aug 13, 2020
BUY
$4.67 - $8.95 $731,354 - $1.4 Million
156,607 Added 23.85%
813,258 $6.77 Million
Q1 2020

May 14, 2020
BUY
$3.95 - $7.4 $336,666 - $630,716
85,232 Added 14.92%
656,651 $3.25 Million
Q4 2019

Feb 13, 2020
BUY
$2.57 - $4.73 $109,150 - $200,887
42,471 Added 8.03%
571,419 $2.26 Million
Q3 2019

Nov 12, 2019
BUY
$3.04 - $5.32 $223,935 - $391,887
73,663 Added 16.18%
528,948 $1.61 Million
Q2 2019

Aug 14, 2019
BUY
$2.46 - $4.52 $119,863 - $220,236
48,725 Added 11.98%
455,285 $2 Million
Q1 2019

May 14, 2019
BUY
$3.51 - $4.77 $196,163 - $266,580
55,887 Added 15.94%
406,560 $1.61 Million
Q4 2018

Feb 13, 2019
BUY
$3.87 - $7.11 $179,107 - $329,057
46,281 Added 15.2%
350,673 $1.4 Million
Q3 2018

Nov 13, 2018
BUY
$5.42 - $6.99 $82,373 - $106,234
15,198 Added 5.26%
304,392 $2.09 Million
Q2 2018

Aug 14, 2018
BUY
$5.99 - $8.17 $327,347 - $446,482
54,649 Added 23.3%
289,194 $1.95 Million
Q1 2018

May 15, 2018
BUY
$4.66 - $7.08 $272,773 - $414,427
58,535 Added 33.26%
234,545 $1.53 Million
Q4 2017

Feb 13, 2018
SELL
$3.73 - $6.37 $44,342 - $75,726
-11,888 Reduced 6.33%
176,010 $783,000
Q3 2017

Nov 14, 2017
BUY
$5.28 - $6.88 $31,748 - $41,369
6,013 Added 3.31%
187,898 $1.16 Million
Q2 2017

Aug 14, 2017
BUY
N/A
181,885
181,885 $1.69 Million

Others Institutions Holding OCUL

# of Institutions
151
Shares Held
136M
Call Options Held
86.4K
Put Options Held
263K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email